Keyphrases
Intravitreal Ranibizumab
100%
Hyperthermia
90%
Sebaceous Carcinoma
80%
Gene Network
77%
Bcl2-associated Athanogene 3 (BAG3)
76%
Eyelid
72%
Macular Edema
60%
Branch Retinal Vein Occlusion
57%
Blepharoplasty
53%
Blepharoptosis
51%
Visual Acuity
49%
After Surgery
45%
Deepening of the Upper Eyelid Sulcus
42%
Oral Squamous Cell Carcinoma Cells
37%
Overexpression
34%
Before Surgery
33%
Lacrimal Gland
33%
Cell Death
33%
Knockdown
33%
Best-corrected Visual Acuity
32%
HSC-3 Cells
32%
Higher-order Aberrations
31%
Human Oral Squamous Cell Carcinoma
31%
Central Macular Thickness
29%
Human Retinoblastoma
28%
Corneal Perforation
28%
Retinoblastoma Cells
28%
Anti-apoptotic Bcl-2
28%
Photodynamic Therapy
28%
Oral Epithelial Cells
28%
Glaucoma
28%
Mild Hyperthermia
28%
Age-related Macular Degeneration
28%
Apoptosis
28%
Molecular Mechanism
26%
Quantitative PCR
24%
Cancer Cells
24%
Surgical Outcomes
24%
University Hospital
22%
Cell Survival
22%
Heat Shock Proteins
22%
Polo-like Kinase 1 (PLK1)
21%
Heat Shock Factor 1 (HSF1)
21%
Excision
21%
MicroRNA
21%
Endoscopic Dacryocystorhinostomy
21%
Tarsus
21%
Orbital Fracture
21%
Eyelid Carcinoma
21%
Intraocular Pressure
21%
Medicine and Dentistry
Eyelid
82%
Ptosis (Eyelid)
78%
Sebaceous Carcinoma
66%
Upper Eyelid
58%
Glaucoma
51%
Macular Edema
42%
Bevacizumab
42%
Branch Retinal Vein Occlusion
42%
Intravitreal Administration
42%
Intraocular Pressure
32%
Visual Acuity
31%
Lacrimal Gland
31%
Corneal Perforation
28%
Hyperthermia
28%
Protein Bcl 2
28%
Antiapoptotic
28%
Intraocular Lens
26%
Lower Eyelid
24%
Neoplasm
23%
Corneal Topography
22%
Dacryocystorhinostomy
21%
Saccadic Eye Movement
21%
Optical Coherence Tomography
20%
Filtering Operation
19%
Best Corrected Visual Acuity
19%
Mouth Squamous Cell Carcinoma
19%
Gene Expression Profiling
18%
Cancer Cell
17%
Diplopia
17%
Androgen Receptor
17%
Retrospective Study
17%
Elderly Patient
16%
Basal-Cell Carcinoma
16%
Malignant Neoplasm
16%
Messenger RNA
15%
Prognostic Factor
15%
Enbucrilate
14%
Knee Meniscus Rupture
14%
Cyclin Dependent Kinase Inhibitor 2A
14%
Cyclin-Dependent Kinase 1
14%
Choroid Melanoma
14%
Pars Plana Vitrectomy
14%
Vitrectomy
14%
Tissue Adhesive
14%
Amnion
14%
Laser Coagulation
14%
Receptor Expression
14%
Adhesive Agent
14%
Proliferating Cell Nuclear Antigen
14%
Reconstructive Surgery
14%